NDC 70771-1513 – Mesalamine
Mesalamine 1000 mg/1 · Suppository · Rectal
Product NDC70771-1513
Product details
- Brand name
- Mesalamine
- Generic name
- Mesalamine
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- Suppository
- Route
- Rectal
- Marketing category
- ANDA · ANDA208953
- Marketed since
- February 14, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Aminosalicylate
Active ingredients
- Mesalamine 1000 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70771-1513-7 | 5 BLISTER PACK in 1 POUCH (70771-1513-7) / 6 SUPPOSITORY in 1 BLISTER PACK (70771-1513-6) | Feb 14, 2020 |
Other Mesalamine products
- 0472-1915 Mesalamine 1000 mg/1 · Suppository · Actavis Pharma, Inc.
- 72162-1804 Mesalamine 1000 mg/1 · Suppository · Bryant Ranch Prepack
- 63629-2397 Mesalamine 1000 mg/1 · Suppository · Bryant Ranch Prepack
- 31722-005 Mesalamine 1000 mg/1 · Suppository · Camber Pharmaceuticals, Inc.
- 16714-245 Mesalamine 1000 mg/1 · Suppository · Northstar Rx LLC.
- 64980-282 Mesalamine 1000 mg/1 · Suppository · Rising Pharma Holdings, Inc.
- 16571-246 Mesalamine 1000 mg/1 · Suppository · Rising Pharma Holdings, Inc.
- 70710-1302 Mesalamine 1000 mg/1 · Suppository · Zydus Pharmaceuticals USA Inc.
- 0591-2245 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Actavis Pharma, Inc.
- 62332-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Limited
- 60687-556 Mesalamine 400 mg/1 · Capsule, Delayed Release · American Health Packaging